Allied Market Research


Cruciate Ligament Diagnosis Treatment Market

Cruciate Ligament Diagnosis Treatment Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by  Injury Type, by Product, by Indication, by Diagnosis, by Treatment and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Healthcare

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Cruciate Ligaments are the pairs of ligaments arranged like the letter X. These ligaments are present at several joints of the body such as the knee joint. The cruciate ligaments of the knee are of two types, anterior cruciate ligament and the posterior cruciate ligament. These two ligaments are rounded and strong bands that extend from the tibia to the femur. The anterior cruciate ligament is lateral while the posterior cruciate ligament is medial. Injuries to these ligaments can cause knee swelling, instability, and pain. The treatment for such injuries may include physiotherapy and knee reconstruction surgeries.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.

With COVID-19 spreading all across the world, hospitalization rates fell down dramatically. There were several reports of many hospitals operating at less than 50% capacity in order to curtail noncritical medical services and elective surgeries. People are even less likely to visit hospitals and clinics for a cruciate ligament diagnosis and treatment. Therefore, COVID-19 is expected to have a significant impact on the cruciate ligament diagnosis treatment market.

Top Impacting Factors

  • The growth in number of knee injury cases that require knee reconstruction surgeries propel the growth of the cruciate ligament diagnosis treatment market. Anterior and posterior cruciate ligaments are present in the middle and back of the knee respectively.
  • The growth in number of people joining sports has led to the growth of the cruciate ligament diagnosis treatment market. Athletes are known to often injure their posterior cruciate ligament which disables complete stretching of their legs, hence making them require reconstruction surgeries.
  • Increase in the geriatric population coupled with rise in incidences of age-related diseases, such as osteoarthritis and rheumatoid arthritis, are also some factors that help in the growth of the cruciate ligament diagnosis treatment market.
  • However, despite these factors, the complications associated with the treatments and a lack of trained physicians especially in developing countries are some of the factors that restrain the growth of the market.

Key Market Trends

In 2018, Orthotaxy, Inc. was acquired by Johnson & Johnson Medical Devices. Orthotaxy is a developer of software-enabled surgery technology. The company has developed a robotic-assisted surgery solution. This acquisition has hence helped develop a robotic-assisted surgery platform in the field of orthopedics.

North America leads the cruciate ligament diagnosis treatment market due to the presence of major players and an advanced healthcare infrastructure with a growth in number of reimbursement policies in health insurances.

Asia-Pacific region is also expected to show major growth in the cruciate ligament diagnosis treatment market owing to the rise in geriatric population, known to be at risk of knee injuries. The geriatric population is substantially high in countries like China and India.

Major key players in the market are MTF Biologics and Bioventus LLC., who are focused on collaborations, mergers, and acquisitions with other key players of the cruciate ligament diagnosis treatment market. These strategies will enable the launch of new products and services for the diagnosis and treatment of cruciate ligament injuries.

Key Benefits of the Report

  • This study presents the analytical depiction of the cruciate ligament diagnosis treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the cruciate ligament diagnosis treatment market share.
  • The current market is quantitatively analyzed to highlight the growth scenario of the cruciate ligament diagnosis treatment.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Cruciate Ligament Diagnosis Treatment Report

  • Which are the leading players active in the cruciate ligament diagnosis treatment market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the cruciate ligament diagnosis treatment market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps in the market?
  • What are the impacts of COVID-19 on the industry?
  • What is cruciate ligament diagnosis treatment?
  • What are the current and predicted trends of the market?

Cruciate Ligament Diagnosis Treatment Market Report Highlights

Aspects Details
By Type
  • Posterior Cruciate Ligament (PCL)
  • Anterior Cruciate Ligament (ACL)
By  Injury Type
  • Grade I
  • Grade II
  • Grade III
By Product
  • Cemented Implants
  • Cement-less Implants
  • Partial Implants
  • Revision Implants
By Indication
  • Osteoarthritis
  • Rheumatoid Arthritis
  • Trauma
  • Others
By Diagnosis
  • Imaging
    • Magnetic Resonance Imaging (MRI)
    • Ultrasound
    • Laparoscopy
    • Others
  • Others
By Treatment
  • Surgery
    • Arthroscopy Anterior
    • Cruciate Ligament Reconstruction
    • Others
  • Therapies
    • Rehabilitation
    • Physical Therapies
    • Others
By End User
  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

BSN Medical GmbH, DJO Global, Conmed, Arthrex, Zimmer Biomet, Bauerfeind AG, Stryker, Smith and Nephew, DeRoyal Industries, 3M Company

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Cruciate Ligament Diagnosis Treatment Market

Global Opportunity Analysis and Industry Forecast, 2023-2032